2,087
Views
2
CrossRef citations to date
0
Altmetric
Perspective

Tusi: a new ketamine concoction complicating the drug landscape

Pages 546-550 | Received 19 Jan 2023, Accepted 24 Apr 2023, Published online: 10 May 2023

References

  • Palamar J, Acosta P. A qualitative descriptive analysis of effects of psychedelic phenethylamines and tryptamines. Hum Psychopharmacol. 2020;35:e2719. doi:10.1002/hup.2719.
  • Palamar JJ, Keyes KM. Trends in drug use among electronic dance music party attendees in New York City, 2016-2019. Drug Alcohol Depend. 2020;209:107889. doi:10.1016/j.drugalcdep.2020.107889.
  • Shulgin A, Shulgin A. PIHKAL: a chemical love story. Berkeley, CA: Transform Press; 2014.
  • Palamar JJ, Le A. Use of new and uncommon synthetic psychoactive drugs among a nationally representative sample in the United States, 2005-2017. Hum Psychopharmacol. 2019;34:e2690. doi:10.1002/hup.2690.
  • United States Department of Justice. 2C-B (Nexus) reappears on the club drug scene. Washington, DC; 2001. https://www.justice.gov/archive/ndic/pubs0/665/665p.pdf.
  • Gonzalez D, Torrens M, Farre M. Acute effects of the novel psychoactive drug 2C-B on emotions. Biomed Res Int. 2015;2015:643878. doi:10.1155/2015/643878.
  • United States Drug Enforcement Administration. 4-Bromo-2,5-Dimethoxyphenethylamine: diversion control division. Drug Chem Eval Sect. 2020. https://www.deadiversion.usdoj.gov/drug_chem_info/bromo_dmp.pdf
  • González D, Ventura M, Caudevilla F, Torrens M, Farre M. Consumption of new psychoactive substances in a Spanish sample of research chemical users. Hum Psychopharmacol. 2013;28:332–40. doi:10.1002/hup.2323.
  • Caudevilla-Gálligo F, Riba J, Ventura M, González D, Farré M, Barbanoj MJ, Bouso JC. 4-Bromo-2,5-dimethoxyphenethylamine (2C-B): presence in the recreational drug market in Spain, pattern of use and subjective effects. J Psychopharmacol. 2012;26:1026–35. doi:10.1177/0269881111431752.
  • Hondebrink L, Nugteren-van Lonkhuyzen JJ, Hunault CC, van den Berg J, van der Gouwe D, van Riel A. New psychoactive substances (NPS) in the Netherlands: occurrence in forensic drug samples, consumer drug samples and poisons center exposures between 2013 and 2017. Addiction. 2020;115:716–25. doi:10.1111/add.14868.
  • U.S. Drug Enforcement Administration. 2C-Phenethylamines, Piperazines, and Tryptamines Reported in NFLIS, 2011–2015. Springfield, VA; 2017.
  • U.S. Drug Enforcement Administration. Forensic Laboratory Information System Special Report: Emerging 2C-Phenethylamines, Piperazines, and Tryptamines in NFLIS, 2006-2011; Springfield, VA; 2012.
  • U.S. Drug Enforcement Administration. National Forensic Laboratory Information System: NFLIS-Drug 2019 Annual Report; Springfield, VA: US; 2020.
  • Palamar JJ, Acosta P, Cleland CM. Attitudes and beliefs about new psychoactive substance use among electronic dance music party attendees. Subst Use Misuse. 2018;53:381–90. doi:10.1080/10826084.2017.1327980.
  • Palamar JJ, Le A, Cleland CM, Keyes KM. Trends in drug use among nightclub and festival attendees in New York City, 2017-2022. Int J Drug Policy. 2023;115:104001. doi:10.1016/j.drugpo.2023.104001.
  • Palamar JJ. Increasing willingness to use synthetic drugs if offered among electronic dance music party attendees, 2017-2019. J Psychoactive Drugs. 2020;52:324–33. doi:10.1080/02791072.2020.1761574.
  • United Nations Office on Drugs and Crime. ”Tuci”, “happy water”, “k-powdered milk” – is the illicit market for ketamine expanding?” 2022.
  • Energy Control. Tusi. https://energycontrol.org/sustancias/tusibi/
  • Díaz Moreno M, Alarcon Ayala A, Quintero J, Morris V, Estrada Y. Échele Cabeza as a harm reduction project and activist movement in Colombia. Drug Habits Social Policy. 2022;23:4. doi:10.1108/DHS-07-2022-0026.
  • DanceSafe. #testit Alert: bag of pink powder sold in Sacramento, CA as 2C-B but actually contains caffeine, ketamine, and MDMA. 2020.
  • Miró Ò, Dargan PI, Wood DM, Dines AM, Yates C, Heyerdahl F, Hovda KE, Giraudon I, Galicia M. Epidemiology, clinical features and management of patients presenting to European emergency departments with acute cocaine toxicity: comparison between powder cocaine and crack cocaine cases. Clin Toxicol. 2019;57:718–26. doi:10.1080/15563650.2018.1549735.
  • Palamar JJ, Acosta P, Le A, Cleland CM, Nelson LS. Adverse drug-related effects among electronic dance music party attendees. Int J Drug Policy. 2019;73:81–87. doi:10.1016/j.drugpo.2019.07.005.
  • DiSalvo P, Cooper G, Tsao J, Romeo M, Laskowski LK, Chesney G, Su MK. Fentanyl-contaminated cocaine outbreak with laboratory confirmation in New York City in 2019. Am J Emerg Med. 2020;40:103–05. doi:10.1016/j.ajem.2020.12.002.
  • Fresno County Sheriff’s Office. HIDTA drug task force seizes $6.8 million in fentanyl and ketamine. https://www.fresnosheriff.org/media-relations/hidta-drug-task-force-seizes-6-8-million-in-fentanyl-and-ketamine.html
  • Kuip EJ, Zandvliet ML, Koolen SL, Mathijssen RH, van der Rijt CC. A review of factors explaining variability in fentanyl pharmacokinetics; focus on implications for cancer patients. Br J Clin Pharmacol. 2017;83:294–313. doi:10.1111/bcp.13129.
  • Oliver CF, Palamar J, Salomone A, Simmons SJ, Philogene-Khalid H, Stokes-McCloskey N, Rawls S. Synthetic cathinone adulteration of illegal drugs. Psychopharmacology. 2018;236:869–79. doi:10.1007/s00213-018-5066-6.
  • Palamar JJ, Salomone A, Gerace E, Di Corcia D, Vincenti M, Cleland CM. Hair testing to assess both known and unknown use of drugs amongst ecstasy users in the electronic dance music scene. Int J Drug Policy. 2017;48:91–98. doi:10.1016/j.drugpo.2017.07.010.
  • Palamar JJ, Rutherford C, Keyes KM. Trends in ketamine use, exposures, and seizures in the United States. Am J Public Health. 2021;111:2046–49. doi:10.2105/AJPH.2021.306486.
  • Palamar JJ. There’s something about Molly: the under-researched yet popular powder form of ecstasy in the United States. Subst Abus. 2017;38:15–17. doi:10.1080/08897077.2016.1267070.
  • Palamar JJ, Salomone A, Keyes KM. Underreporting of drug use among electronic dance music party attendees. Clin Toxicol. 2021;59:185–92. doi:10.1080/15563650.2020.1785488.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.